Oligonucleotide drug producers coauthor report on drug impurities
(PHYSorg.com Medicine & Health)

A new addition to a series of articles that focus on important topics related to the development of oligonucleotide therapeutics presents an in-depth look at the identification, characterization, and reporting of product-related impurities. The article entitled `Impurities in Oligonucleotide Drug Substances and Drug Products,` which covers both the chemistry and safety aspects of impurities and provides scientific advice on impurity qualification requirements, is published in Nucleic Acid Therapeutics.